Medicalgorithmics S.A. — AGM Information 2023

Nov 23, 2023

Informationon convening the Extraordinary General Meeting of Medicalgorithmics S.A.together with the content of draft resolutions

Currentreport no.: 33/2023

Date:22.11.2023

Legalbasis: Article 56 (1) (2) of the Offering Act - current and periodicinformation

ManagementBoard of Medicalgorithmics S.A. with its seat in Warsaw (_quot;theCompany_quot;), hereby informs about the convening of the ExtraordinaryGeneral Meeting of the Company on December 19, 2023, at 3:30 p.m. at theCompany's seat - at the office at Al. Jerozolimskie 81, 02-001 Warsaw,on the 18th floor of the Central Tower building in Warsaw, in accordancewith the content of the announcement attached to this current report.

Attachedto this current report, the Company provides the content of draftresolutions to be discussed at the Extraordinary General Meeting of theCompany.

TheCompany indicates that the adoption of the proposed resolutions is aimedat adopting the Remuneration Policy, in accordance with the requirementsof the Act on Offering and the provisions of the Company's existingRemuneration Policy for Members of the Company's Management Board andSupervisory Board, which requires it to be updated or left unchanged atleast once every 3 years, and introducing an incentive program at theCompany for members of the Company's Management Board and key personnel(the_quot;Incentive Program_quot;). Incentive mechanisms as presentedin the draft Incentive Program and key assumptions of the IncentiveProgram were submitted to the Company's Management Board by theCompany's shareholder BioFund Capital Management LLC, which owns 49.99%of the Company's shares, and subsequently submitted to the Nominationand Remuneration Committee and the Company's Supervisory Board for workand received a positive opinion. In the opinion of the Company'sManagement Board, the presented shape of the Incentive Program coincideswith the interests of shareholders and the Company, and at the same timewill significantly increase the competitiveness of the MedicalgorithmicsGroup as an employer.

Detailedlegal basis:§ 19 para. 1 point 1) and 2) of the Regulation of the Minister ofFinance of March 29, 2018, on current and periodic information publishedby issuers of securities and conditions for recognizing as equivalentinformation required by the law of a non-member state.